Pre$cription for Power: Patient Advocacy Groups Take In Millions From Drugmakers. Is There A Payback? Kaiser Health News (KHN) has launched “Pre$cription for Power,” a groundbreaking database to expose Big Pharma’s ties to patient groups. Pharmaceutical companies gave at...
The W. Maurice Young Centre for Applied Ethics presents: "How Purdue was allowed to push OxyContin in Canada" When: Thursday, May 17, 2018 at 3:00 - 4:30 PM Where: UBC School of Population and Public Health, Room B104 Speaker:...
Empagliflozin (Jardiance) inhibits the sodium-glucose co-transporter 2 (SGLT2), which is the predominant mechanism responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. By inhibiting SGLT2, empagliflozin increases urinary glucose excretion.1 Empagliflozin...
People understand different things by this term, and the arguments don’t divide along predictable partisan lines, either. By Aaron E. Carroll Dec. 27, 2017 Read more...